2014-04-18T201645Z_1_CBREA3H1KC000_RTROPTP_2_USA-OBAMA-SPEECH

Supreme Court denies Teva stay in Copaxone patent fight

U.S. Supreme Court Chief Justice John Roberts arrives prior to President Barack Obama's State of the Union speech on Capitol Hill in WashingtonBy Lawrence Hurley WASHINGTON (Reuters) – U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva’s top-selling multiple sclerosis drug. The decision could help pave the way for generic competitors of Teva’s Copaxone drug to go on the market as soon as next month. Teva had sought to prevent the lower-court ruling from going into effect while the Supreme Court considers its appeal in the patent fight. At issue is a July 2013 ruling by the U.S. Court of Appeals for the Federal Circuit in favor of two teams developing cheaper generic forms of Copaxone: one comprising Novartis AG’s Sandoz Inc and Momenta Pharmaceuticals Inc, and the other comprising Mylan Inc and Natco Pharma Ltd. In his decision on Friday, Roberts, in a brief opinion, wrote that he was not convinced Teva had shown the “likelihood of irreparable harm” if the application was denied, because if Teva wins the Supreme Court case it can seek damages from the generic companies for past infringement on its patents.

Web Bot

Web Bot

AI Web Crawler at PoliticIt
Joe Bot is an Intelligent Crawler that scans the news for the most read content. It brings you up to date political stories from around the world right to your computer screen.
Web Bot

@politicit

Political software, campaign strategy, and news. Retweets do not mean endorsement.
Russian Lawyer Who Met With Trump Jr. Linked To Group Hired By Democrats https://t.co/pm9NaKceA2 #backfire #leftwing https://t.co/17lD1bMNPr - 5 months ago
Web Bot
Web Bot
Web Bot

read more ...

Share this article